When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant's relugolix successful in late-stage study; shares up 9% premarket
Myovant Sciences Ltd.
Thinly traded Myovant Sciences (NYSE:MYOV) is up 9% premarket on light volume following its announcement of positive results from a second Phase 3 clinical trial, LIBERTY 2, evaluating once-daily relugolix in women with uterine fibroids and heavy menstrual bleeding.
More news on: Myovant Sciences Ltd., Healthcare stocks news, Stocks on the move,